Ashok Balasubramanyam Selected Research

Ketosis

10/2021	Pancreatic Differentiation of Stem Cells Reveals Pathogenesis of a Syndrome of Ketosis-Prone Diabetes.
1/2021	Metabolomics Profiling of Patients With A-β+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis.
1/2019	Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640.
12/2018	Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes.
1/2018	Elevated unmethylated and methylated insulin DNA are unique markers of A+β+ ketosis prone diabetes.
1/2016	Pyruvate Dehydrogenase Activity Is Decreased in Emergency Department Patients With Diabetic Ketoacidosis.
9/2015	Factors associated with early relapse to insulin dependence in unprovoked A-β+ ketosis-prone diabetes.
6/2014	Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.
12/2013	Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.
11/2012	Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashok Balasubramanyam Research Topics

Disease

15	Insulin Resistance 01/2022 - 05/2004
15	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2004
15	Ketosis 10/2021 - 11/2003
12	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 11/2003
11	Dyslipidemias (Dyslipidemia) 04/2016 - 02/2004
10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 01/2003
8	Overweight 12/2018 - 06/2011
8	Lipodystrophy 09/2013 - 02/2004
7	Obesity 01/2022 - 06/2011
7	Weight Loss (Weight Reduction) 12/2018 - 10/2006
7	Hypertriglyceridemia 07/2013 - 08/2002
5	HIV-Associated Lipodystrophy Syndrome 10/2012 - 08/2002
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2006
4	Hyperglycemia 01/2018 - 05/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2013 - 02/2004
3	Inflammation (Inflammations) 01/2018 - 05/2004
3	HIV Infections (HIV Infection) 09/2013 - 06/2007
2	Acanthosis Nigricans 01/2022 - 05/2007
2	Morbid Obesity 01/2021 - 12/2018
2	Dementia (Dementias) 12/2018 - 01/2017
2	Fatty Liver 10/2017 - 09/2012
2	Non-alcoholic Fatty Liver Disease 10/2017 - 09/2012
2	Diabetes Mellitus 02/2016 - 08/2013
2	Infections 06/2013 - 07/2006
2	Body Weight (Weight, Body) 10/2006 - 08/2005
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Cognitive Dysfunction 12/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2021
1	Hypersensitivity (Allergy) 10/2021
1	Neoplasms (Cancer) 12/2019
1	Insulinoma 12/2018
1	Ovotesticular Disorders of Sex Development 01/2016

Drug/Important Bio-Agent (IBA)

18	AutoantibodiesIBA 01/2022 - 11/2003
13	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2006
13	Insulin (Novolin)FDA Link 01/2021 - 12/2004
9	Triglycerides (Triacylglycerol)IBA 01/2021 - 06/2005
9	LipidsIBA 12/2019 - 11/2004
8	HDL CholesterolIBA 01/2021 - 08/2002
7	C-PeptideIBA 01/2022 - 11/2012
5	AdiponectinIBA 08/2015 - 12/2006
4	LeptinIBA 10/2012 - 10/2006
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 08/2013
3	AntibodiesIBA 01/2021 - 02/2007
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 12/2018 - 01/2014
3	Hypoglycemic Agents (Hypoglycemics)IBA 12/2018 - 12/2004
3	HLA Antigens (Human Leukocyte Antigens)IBA 06/2014 - 11/2003
3	EpitopesIBA 06/2014 - 02/2007
3	Niacin (Nicotinic Acid)FDA LinkGeneric 07/2011 - 12/2006
3	Fenofibrate (CiL)FDA LinkGeneric 07/2011 - 06/2004
3	ThiazolidinedionesIBA 08/2010 - 12/2004
2	Peptides (Polypeptides)IBA 01/2022 - 08/2005
2	CreatinineIBA 12/2021 - 07/2006
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2007
2	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2017
2	Leucine (L-Leucine)FDA Link 10/2021 - 01/2021
2	KetonesIBA 01/2021 - 01/2016
2	Zinc Transporter 8IBA 12/2018 - 01/2014
2	Indicators and Reagents (Reagents)IBA 12/2018 - 01/2017
2	Arginine (L-Arginine)FDA Link 01/2018 - 07/2006
2	vpr Gene ProductsIBA 10/2017 - 09/2013
2	C-Reactive ProteinIBA 02/2016 - 07/2011
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 01/2014
2	Lipoproteins (Lipoprotein)IBA 07/2013 - 12/2006
2	Cholesterol Esters (Cholesteryl Esters)IBA 07/2013 - 12/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2012 - 08/2010
2	Adenosine Triphosphate (ATP)IBA 09/2012 - 12/2006
2	Rosiglitazone (Avandia)FDA Link 06/2011 - 12/2004
2	very low density lipoprotein triglycerideIBA 06/2011 - 12/2006
2	Growth Hormone (Somatotropin)IBA 08/2010 - 07/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2010 - 11/2004
2	Fibric Acids (Fibrates)IBA 08/2010 - 11/2004
1	Growth Differentiation Factor 15IBA 01/2022
1	AlbuminsIBA 12/2021
1	NAD (NADH)IBA 12/2021
1	NucleotidesIBA 10/2021
1	Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2021
1	Iodide Peroxidase (Deiodinase)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Thyroglobulin FDA Link 01/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2019
1	Tyrosine (L-Tyrosine)FDA Link 12/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2018
1	ICA512 autoantibodyIBA 12/2018
1	OrnithineIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 04/2016
1	CholesterolIBA 04/2016
1	GlucokinaseIBA 02/2016
1	glucokinase regulatory proteinIBA 02/2016
1	Pyruvic Acid (Pyruvate)IBA 01/2016
1	AcidsIBA 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2016

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2004
8	Highly Active Antiretroviral Therapy (HAART) 07/2013 - 02/2004
2	Glycemic Control 11/2005 - 12/2004